Carbamyl Forte 150/2.5mg Tablet 10s

Carbamyl Forte 150/2.5mg Tablet 10s combines the antifilarial activity of diethylcarbamazine with the antihistaminic properties of chlorpheniramine maleate to manage filarial infections and their associated immunological reactions.

Diethylcarbamazine (DEC) is the drug of choice for lymphatic filariasis caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori, as well as loiasis caused by Loa loa and tropical pulmonary eosinophilia. It acts by immobilising and killing microfilariae and adult worms through multiple mechanisms. DEC sensitises filarial parasites to immune-mediated destruction by altering their surface membranes and inhibiting arachidonic acid metabolism, making them susceptible to the host's immune system.

The destruction of microfilariae releases parasite antigens that trigger significant host inflammatory and hypersensitivity responses including fever, urticaria, pruritus, angioedema, and systemic reactions known collectively as Mazzotti reactions. These reactions can be severe and distressing, particularly in heavily infected individuals.

Chlorpheniramine maleate is a first-generation alkylamine antihistamine that competitively blocks H1 histamine receptors, reducing histamine-mediated allergic symptoms including pruritus, urticaria, rhinorrhoea, and angioedema. Its inclusion in this combination directly addresses the histamine-driven component of treatment-associated hypersensitivity reactions, improving tolerability and reducing the severity of Mazzotti reactions during antifilarial therapy.

The uses of Carbamyl Forte 150/2.5mg Tablet 10s are as follows:

Lymphatic Filariasis

Carbamyl Forte 150/2.5mg Tablet 10s is used to treat lymphatic filariasis caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori, reducing microfilarial load and targeting adult worms.

Tropical Pulmonary Eosinophilia

DEC is the treatment of choice for this filarial-related pulmonary hypersensitivity syndrome, with chlorpheniramine managing associated allergic symptoms.

Loiasis

It is used under specialist supervision in infections caused by Loa loa.

Management of Mazzotti Reactions

Chlorpheniramine mitigates the histamine-mediated hypersensitivity reactions triggered by microfilarial destruction during DEC therapy.

Filarial-Associated Pruritus and Urticaria

The antihistaminic component provides symptomatic relief of skin reactions associated with filarial infection and its treatment.

Here are the benefits of Carbamyl Forte 150/2.5mg Tablet 10s:

• Targeted Antifilarial Activity: DEC effectively reduces microfilarial load and targets adult filarial worms, addressing the root cause of infection.

• Improved Treatment Tolerability: Chlorpheniramine reduces the severity of Mazzotti reactions, making DEC therapy better tolerated, particularly in heavily infected patients.

• Dual Symptom and Infection Management: A single combination formulation simultaneously treats the infection and manages its associated allergic manifestations.

• Reduces Transmission: By lowering microfilarial density in the bloodstream, DEC reduces the potential for mosquito-mediated transmission of filariasis.

• Effective in Tropical Pulmonary Eosinophilia: DEC is the drug of choice for this condition and chlorpheniramine provides concurrent management of allergic respiratory and skin symptoms.

Like all medicines, Carbamyl Forte 150/2.5mg Tablet 10s may cause side effects in some individuals.

Common Side Effects

• Drowsiness and Sedation: Chlorpheniramine causes central sedation due to blood-brain barrier penetration and H1 receptor blockade.

• Nausea and Gastrointestinal Discomfort: Particularly with DEC, nausea and abdominal discomfort are commonly reported.

• Headache: Frequently reported during early treatment, related to both the antiparasitic and antihistaminic components.

• Dizziness: Light-headedness may occur with chlorpheniramine-related sedation.

Uncommon Side Effects

• Dry Mouth: Anticholinergic activity of chlorpheniramine reduces salivary secretion.

• Fever: Treatment-related fever from microfilarial destruction may occur during initial DEC therapy.

• Skin Rash or Urticaria: Mazzotti reactions may cause transient urticarial eruptions despite antihistamine cover.

Serious Side Effects (Require Immediate Medical Attention)

• Severe Mazzotti Reaction: Intense fever, hypotension, bronchospasm, and severe urticaria may occur in heavily infected patients, requiring medical management.

• Encephalopathy in High Loa loa Microfilaraemia: DEC in patients with very high Loa loa microfilarial counts may precipitate severe encephalopathy; specialist assessment is essential before treatment.

• Severe Allergic Reaction: Swelling of the face, lips, or throat with difficulty breathing requires urgent medical care.

Always consult your doctor if side effects persist or worsen.

To ensure safe use:

• Use exactly as prescribed by your doctor.

• Usually taken orally with food to reduce gastrointestinal discomfort.

• Take at the same time each day throughout the prescribed course.

• Complete the full course as directed even if symptoms improve.

• Do not discontinue without consulting your doctor.

Carbamyl Forte 150/2.5mg Tablet 10s works through complementary antiparasitic and antihistaminic mechanisms.

Diethylcarbamazine acts on filarial parasites through two principal mechanisms. It alters the surface membranes of microfilariae by inhibiting arachidonic acid metabolism, disrupting their ability to evade host immune detection. This exposes the parasites to immune-mediated attack including antibody-dependent cellular cytotoxicity and complement activation. DEC also has direct effects on filarial neuromuscular function, causing immobilisation and paralysis of microfilariae. The resulting immune-mediated destruction of large numbers of microfilariae releases parasite antigens, triggering the histamine-mediated hypersensitivity cascade responsible for Mazzotti reactions.

Chlorpheniramine competitively blocks H1 histamine receptors at both peripheral and central sites, preventing histamine from mediating vasodilation, increased vascular permeability, pruritus, urticaria, and angioedema. By attenuating the histamine component of the Mazzotti reaction, it reduces the severity and discomfort of treatment-associated hypersensitivity without interfering with the antiparasitic mechanism of DEC.

A few practical measures can help improve outcomes and ensure safe use of Carbamyl Forte 150/2.5mg Tablet 10s:

• Take with food: Reduces DEC-associated gastrointestinal discomfort and nausea, particularly during the initial days of treatment.

• Do not drive during treatment: Chlorpheniramine causes significant sedation; avoid all activities requiring alertness throughout the course.

• Report high fever or severe reactions promptly: Intense Mazzotti reactions may require additional medical management beyond antihistamine cover, particularly in heavily infected individuals.

• Avoid alcohol entirely: The combination of alcohol and chlorpheniramine produces dangerous additive CNS depression.

• Complete the full course: Incomplete treatment may not adequately reduce microfilarial load and adult worm burden, risking treatment failure and ongoing transmission.

Proper storage is important to maintain the stability and effectiveness of Carbamyl Forte 150/2.5mg Tablet 10s:

• Store at room temperature: Keep away from heat, moisture, and direct sunlight.

• Keep in original packaging: Protects tablets from humidity and light.

• Keep out of reach of children: Store safely to prevent accidental ingestion.

• Check expiry before use: Do not use after the expiry date printed on the packaging.

Carbamyl Forte 150/2.5mg Tablet 10s may generally be taken without strict dietary restrictions. However:

• Take with food: Reduces gastrointestinal side effects of DEC.

• Avoid alcohol: Significantly enhances sedation from chlorpheniramine and must be avoided throughout treatment.

• No other significant dietary restrictions apply: General nutritional intake does not require modification during treatment.

Carbamyl Forte 150/2.5mg Tablet 10s may interact with the following medicines:

• CNS Depressants and Sedatives: Additive CNS depression with benzodiazepines, opioids, and other sedatives increases respiratory depression risk.

• MAO Inhibitors: May intensify and prolong the anticholinergic effects of chlorpheniramine; concurrent use requires medical review.

• Other Anticholinergic Medicines: Additive anticholinergic effects increase the risk of urinary retention, constipation, and confusion.

• Anticoagulants: DEC may potentiate the effects of anticoagulant medicines in some patients; monitoring is advisable.

Carbamyl Forte 150/2.5mg Tablet 10s should be used carefully in the following conditions:

• High Loa loa Microfilaraemia: DEC in patients with very high Loa loa counts may precipitate severe or fatal encephalopathy. Specialist assessment and microfilarial count measurement before treatment are essential.

• Glaucoma: Anticholinergic effects of chlorpheniramine may raise intraocular pressure and precipitate acute angle-closure glaucoma in predisposed individuals.

• Benign Prostatic Hyperplasia: Urinary retention risk is increased by chlorpheniramine's anticholinergic activity.

• Epilepsy: Chlorpheniramine may lower the seizure threshold in susceptible individuals.

• Renal Impairment: DEC is primarily renally excreted; dose reduction may be necessary in significant renal impairment.

Dose and frequency depend on the specific filarial infection, patient weight, and the prescribing doctor's recommendation. Usually taken in divided doses daily with food throughout the prescribed course as directed by your doctor.

If a dose is missed, take it as soon as remembered. However, if it is close to the time of the next scheduled dose, skip the missed dose and continue the regular schedule. Do not double the dose to compensate for a missed one.